Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer
NCT ID: NCT00062400
Last Updated: 2013-10-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
385 participants
INTERVENTIONAL
2003-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying young women's attitudes and feelings about the risk of infertility related to adjuvant therapy for stage I or stage II breast cancer.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Determine the attitude toward the risk of infertility related to adjuvant therapy in women with early breast cancer.
* Correlate, if possible, the patient's attitude with the fact that the patient already has children or the time interval between the date of breast cancer diagnosis and the date of study participation.
OUTLINE: This is a multicenter study.
Patients complete a questionnaire administered by a nontreating physician.
PROJECTED ACCRUAL: A total of 385 patients will be accrued for this study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
psychosocial assessment and care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Histologically or cytologically confirmed prior or current diagnosis of breast cancer
* Stage I or II
* No relapsed disease
* No evidence of infertility
* Regular menses or regular hormonal contraception use for the past 3 months
* Hormonal status:
* Not specified
PATIENT CHARACTERISTICS:
Age
* 35 and under at diagnosis
Sex
* Female
Menopausal status
* Premenopausal
Performance status
* Not specified
Life expectancy
* Not specified
Hematopoietic
* Not specified
Hepatic
* Not specified
Renal
* Not specified
Other
* No psychological, familial, sociological, or geographical condition that would preclude study compliance
PRIOR CONCURRENT THERAPY:
Biologic therapy
* Not specified
Chemotherapy
* Not specified
Endocrine therapy
* See Disease Characteristics
Radiotherapy
* Not specified
Surgery
* Not specified
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Adjuvant Breast Cancer Group
OTHER
ETOP IBCSG Partners Foundation
NETWORK
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zora Neskovic-Konstantinovic
Role: STUDY_CHAIR
Institute Of Oncology & Radiology, Belgrade, Serbia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Jules Bordet
Brussels, , Belgium
Centre Hospitalier Etterbeek Ixelles
Brussels, , Belgium
CHU Liege - Domaine Universitaire du Sart Tilman
Liège, , Belgium
Algemeen Ziekenhuis Sint-Augustinus
Wilrijk, , Belgium
Instituto de Radiomedicina
Santiago, , Chile
Clinica Alemana
Santiago, , Chile
Hospital Militar
Santiago, , Chile
University Hospital Rebro
Zagreb, , Croatia
Klinikum der J.W. Goethe Universitaet
Frankfurt, , Germany
Universitatsklinikum Heidelberg
Heidelberg, , Germany
Centro di Riferimento Oncologico - Aviano
Aviano, , Italy
Azienda Istituti Ospitalieri
Cremona, , Italy
Ospedale Alessandro Manzoni
Lecco, , Italy
European Institute of Oncology
Milan, , Italy
American University of Beirut Medical Center
Beirut, , Lebanon
Academisch Medisch Centrum at University of Amsterdam
Amsterdam, , Netherlands
Arnhems Radiotherapeutisch Instituut
Arnhem, , Netherlands
Instituto Nacional de Enfermedades Neoplasicas
Lima, , Peru
Medical University of Gdansk
Gdansk, , Poland
Instituto Portugues de Oncologia de Francisco Gentil - Centro Regional de Oncologia de Lisboa, SA
Lisbon, , Portugal
Institute of Oncology and Radiology of Serbia
Belgrade, , Serbia
Groote Schuur Hospital
Cape Town, , South Africa
Inselspital Bern
Bern, , Switzerland
Ospedale Beata Vergine
Mendrisio, , Switzerland
Kantonsspital - St. Gallen
Sankt Gallen, , Switzerland
Marmara University Hospital
Istanbul, , Turkey (Türkiye)
Western Infirmary
Glasgow, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Neskovic-Konstantinovic Z, Gomez H, Senkus-Konefka E, et al.: A Breast International Group survey of young breast cancer patients attitudes towards the risk of loss of fertility related to adjuvant therapies: EORTC protocol 10002 - BIG 3-98. [Abstract] 31st Annual San Antonio Breast Cancer Symposium, December 10-14, 2008, San Antonio, Texas. A-3106, 2008.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EORTC-10002
Identifier Type: -
Identifier Source: secondary_id
BIG-3-98
Identifier Type: -
Identifier Source: secondary_id
IBCSG-29-03
Identifier Type: -
Identifier Source: secondary_id
EORTC-10002
Identifier Type: -
Identifier Source: org_study_id